August 2026
461 articles-
Aug 31 · 20:22Biotechnology Daily
Novartis Halts CAR-T Trials After Three Patient Deaths
-
Aug 31 · 17:53World News
White House Signs Nine Drugmakers to Price-Cut Deals
-
Aug 31 · 16:05Market Watch
Three High-Yield Names Draw Cash Away From the AI Trade
-
Aug 31 · 14:52Market Watch
Insider Buying Lands on Elanco and Two Private-Stage Biotechs
-
Aug 31 · 13:44Bio Business News
Electra Therapeutics Files for Nasdaq IPO to Fund Phase 2/3 Push
-
Aug 31 · 12:34Market Watch
Pfizer's 1.4% Bounce, Starbucks Slips: Two Turnarounds Diverge
-
Aug 31 · 11:23Biotechnology Daily
AstraZeneca's Oral Relaxin Drug Clears Phase 2b Bar at ESC26
-
Aug 31 · 09:54Bio Business News
Metriport Pulls In $26 Million to Speed Patient Record Retrieval
-
Aug 31 · 09:27Biotechnology Daily
Repatha Cuts Death Risk 20% in 12,000-Patient Amgen Trial
-
Aug 31 · 08:51Bio Business News
Lilly Pays Up to $2.88 Billion for Merida Biosciences
-
Aug 30 · 20:25Biotechnology Daily
Roche Widens FDA Clearance for Test Behind Jazz's Ziihera
-
Aug 30 · 17:55Bio Business News
Osivax Licenses GC Biopharma Flu Vaccine for Combination Shot
-
Aug 30 · 16:05Biotechnology Daily
Tessier-Lavigne Releases Emails to Rebut Book's Fraud Claims
-
Aug 30 · 14:57Biotechnology Daily
FDA Clears Roivant's Dermatomyositis Drug, but ROIV Slides 7.6%
-
Aug 30 · 13:44Biotechnology Daily
Arrowhead's Redemplo Data Puts Ionis on Notice in Munich
-
Aug 30 · 12:35Biotechnology Daily
Wainua Trial Miss Puts AstraZeneca's Amyloidosis Bet in Doubt
-
Aug 30 · 11:25Biotechnology Daily
Cytokinetics Puts a Second Approval in Reach as CYTK Slides 7.5%
-
Aug 30 · 09:59Biotechnology Daily
AstraZeneca's Heart Trial Miss Casts Doubt on Silencer Drugs
-
Aug 30 · 09:25Biotechnology Daily
Cytokinetics Takes Myqorzo Data to Munich as CYTK Falls 7.5%
-
Aug 30 · 08:47Biotechnology Daily
AstraZeneca's Relaxin Pill Splits Its Mid-Stage Heart Data
-
Aug 29 · 20:21Market Watch
Orman to Woman Who Sold Biotech Under Pressure: Count the Breakup
-
Aug 29 · 17:56Bio Business News
Daiichi Sankyo Hands Ken Keller a Rebuilt Commercial Org
-
Aug 29 · 16:03Bio Business News
BioXcel Falls 74.8% as Teva Bids $57.5 Million in Bankruptcy
-
Aug 29 · 14:58Biotechnology Daily
FDA Clears Gilead's Bixlenvo as a Biktarvy Switch Option